Ticker Details
BeiGene, Ltd. American Depositary Shares
IPO Date:	July 25, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$42.36B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$4.50 | 1.55%
Avg Daily Range (30 D):	$4.02 | 1.20%
Avg Daily Range (90 D):	$4.09 | 1.33%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.36M
Avg Daily Volume (90 D):	.27M

Trade Size
Avg Trade Size (Sh.):	31
Avg Trade Size (Sh.) (30 D):	25
Avg Trade Size (Sh.) (90 D):	25

Institutional Trades
Total Institutional Trades:	632
Avg Institutional Trade:	$6.83M
Avg Institutional Trade (30 D):	$9.67M
Avg Institutional Trade (90 D):	$7.58M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$7.04M
Avg Closing Trade (30 D):	$11.04M
Avg Closing Trade (90 D):	$8.18M
Avg Closing Volume:	24.34K

News

May 13, 2026 @ 10:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: Na

Mar 23, 2026 @ 1:00 PM Molecular Partners Publishes Invitation to Annual ... Source: Na

Feb 12, 2026 @ 11:00 AM Zymeworks To Report Fourth Quarter and Full Year 2... Source: Na

Jan 29, 2026 @ 5:28 PM FDA Accepts Summit's Lung Cancer Drug Application,... Source: Vandana Singh

Jan 27, 2026 @ 11:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.16	$.16	$.04
Diluted EPS	$.16	$.15	$.04
Revenue	$1.71B	$1.51B	$1.5B
Gross Profit	$1.53B	$1.35B	$1.36B
Net Income / Loss	$237.01M	$227.36M	$66.5M
Operating Income / Loss	$325.05M	$249.9M	$185.04M
Cost of Revenue	$174.53M	$167.22M	$142.42M
Net Cash Flow	$427.25M	$243.78M	$499.11M
PE Ratio